Randomized comparison of nab-paclitaxel weekly or every 3 weeks compared to docetaxel every 3 weeks as first-line therapy in patients (pts) with metastatic breast cancer (MBC) W GRADISHAR,D KRASNOJON,S CHEPOROV,A MAKHSON,G MANIKHAS, A CLAWSON,P BHAREJC SUPPLEMENTS（2008）引用 9|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
